Switzerland-based Nestle announced the launch of China’s first “foods for special medical purposes” (FSMP) product specifically designed for cancer patients. Branded as Oral Impact Su Yi Su, the product provides a non-inflammatory diet for individuals recovering from cancer treatment, containing arginine, fish oil, omega-3, and nucleotides in addition to standard nutritional components.
Addressing Malnutrition in Cancer Patients
FSMPs are used to provide nutritional support as part of medical treatment. According to Nestle, a recent study found that 57% of patients with malignant tumors experience severe malnutrition during treatment, which can impact treatment success. The oncology-focused FSMP was approved after a five-year regulatory process.
Market Context
In China, a total of 83 FSMPs are approved, with 54 produced locally and 29 imported. Nestle leads with 11 approved FSMPs, followed by Abbott Laboratories with 8. Domestic firms Synutra, Suzhou Hengrui, and Jilin Maifu Nutrition are also key players in the market.-Fineline Info & Tech
